跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
death receptor 5 agonist
首页
药物
death receptor 5 agonist
death receptor 5 agonist
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
COMPOSITIONS AND METHODS FOR MAKING AND USING BISPECIFIC ANTIBODIES
US 2020283537 A1
申请人: UNIV VIRGINIA PATENT FOUNDATION
优先权: 2017
US
WO
2 件公开
Use of serotonin 5-HT1A receptor agonists to treat diseases associated with sudden unexpected death in epilepsy
US 11974992 B2
申请人: NEUROLIXIS
优先权: 2022
CN
US
2 件公开
COMBINATIONS OF A CALCIUM HOMEOSTASIS DISRUPTOR WITH A DEATH RECEPTOR 5 AGONIST FOR TREATING CANCER
EP 4631501 A1
申请人: STICHTING HET NEDERLANDS KANKER INST ANTONI VAN LEEUWENHOEK ZIEKENHUIS
优先权: 2024
EP
WO
2 件公开
Compositions and methods for treating pancreatitis and pain with death receptor agonists
US 11084879 B2
申请人: UNIV JOHNS HOPKINS
优先权: 2017
US
USE OF ENDOTHELIN RECEPTOR TYPE B AGONISTS FOR THE TREATMENT OF AORTIC VALVE STENOSIS
US 20250325636 A1
申请人: INST NAT SANTE RECH MED
优先权: 2022
US
STRATEGY FOR HIGHLY SUPERIOR DR5 ACTIVATION INCLUDING IN TUMORS AND CANCERS
US 20250376532 A1
申请人: UNIV VIRGINIA PATENT FOUNDATION
优先权: 2022
US
BEXICASERIN FOR USE IN A METHOD OF TREATMENT OF SEIZURE-INDUCED SUDDEN UNEXPECTED DEATH IN EPILEPSY
WO 2026043678 A1
申请人: ARENA PHARMACEUTICALS INC
优先权: 2024
WO
Application of combination of DR5 agonist and immune checkpoint inhibitor in preparation of medicine for treating tumors
CN 122251603 A
申请人: SUN YAT SEN UNIVERSITY CANCER CENTER SUN YAT SEN UNIVERSITY AFFILIATED CANCER HOSPITAL SUN YAT SEN U
优先权: 2026
CN
药物
反馈